8/104 sources · 4 publishersUpdated Nov 1, 15:15 UTC
AbbVie raises 2026 revenue and adjusted EPS outlook and hikes dividend
AbbVie reported third‑quarter 2026 sales of $17.404 billion, up 10.3% year over year, and adjusted earnings of $3.82 per share. The company lifted its full‑year 2026 revenue forecast to $67.8 billion and its adjusted EPS guidance to $13.95‑$13.99. It also increased the quarterly dividend 5.2% to $1.82 per share, sending the stock to a record $294.89.
Why it matters
The higher revenue and earnings guidance suggest stronger future profitability, which may support the stock price. The dividend increase improves cash returns to shareholders while the payout ratio is expected to fall as earnings grow.
Key facts
- 1Third‑quarter 2026 sales were $17.404 billion, up 10.3% year over year (reported basis). tradingview.com
- 2Adjusted earnings for the quarter were $3.82 per share. tradingview.com
- 3Full‑year 2026 revenue forecast was raised to $67.8 billion. finimize.com
- 4Adjusted EPS guidance for 2026 was raised to $13.95‑$13.99 per share. seekingalpha.com
- 5Quarterly dividend was increased 5.2% to $1.82 per share. tradingview.com
- 6The stock closed at a record $294.89. finance.yahoo.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.